Aug 10, 2026
Novo Nordisk (NVO) Stock Plunges: Bernstein Warns of 33% Drop Amid Eli Lilly Rivalry
Bernstein warns of 33% downside for Novo Nordisk (NVO) stock, slashing EPS estimates as Eli Lilly's competitive threat intensifies in GLP-1 obesity drugs.
The post Novo Nordisk (NVO) Stock Plunges: Bernstein Warns of 33% Drop Amid Eli Lilly Rivalry appeared first on Blockonomi.
Source: Blockonomi →Related News
- 53 minutes ago
ARK Invest Exits AMD (AMD) Position, Reallocates to Broadcom and Cerebras
- 59 minutes ago
PayPal (PYPL) Plunges 13% After Stripe-Advent Consortium Abandons Takeover Bid
- 1 hour ago
Rubrik (RBRK) Stock Drops 8% Despite Strong Q2 Earnings Beat and Raised Guidance
- 1 hour ago
Autodesk (ADSK) Stock Slides 4% After Fiscal 2027 Earnings Outlook Disappoints
- 1 hour ago
Broadcom (AVGO) Stock: Should You Buy Ahead of Wednesday’s Earnings Report?